Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Oxaliplatin+S-1
DRUG
3 trials
Sponsors
Lin Chen
, Chinese PLA General Hospital
, Sixth Affiliated Hospital, Sun Yat-sen University
Conditions
Chemotherapy Effect
Gastric Adenocarcinoma
Gastric Carcinoma
Locally Advanced Gastroesophageal Junction Adenocarcinoma
Phase 1
Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96
NCT02317471
Chinese PLA General Hospital
Gastric Carcinoma
Start: 2014-11-30
End: 2017-12-31
Target: 45
Updated: 2016-06-06
Phase 2
S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma
Recruiting
NCT04989985
Sixth Affiliated Hospital, Sun Yat-sen University
Chemotherapy Effect, Locally Advanced Gastroesophageal Junction Adenocarcinoma
Start: 2021-09-01
End: 2027-08-01
Target: 302
Updated: 2021-08-04
Phase 3
SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer
NCT01583361
Lin Chen
Gastric Adenocarcinoma
Start: 2012-03-31
End: 2017-01-31
Target: 772
Updated: 2012-04-24
Related Papers
Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial.
2024-04-08
17 citations
Early assessment of circulating exosomal lncRNA-GC1 for monitoring neoadjuvant chemotherapy response in gastric cancer
International Journal of Surgery
2023-04-10
8 citations
Early results of the randomized, multicenter, controlled evaluation of S-1 and oxaliplatin as neoadjuvant chemotherapy for Chinese advanced gastric cancer patients (RESONANCE Trial).
Journal of Clinical Oncology
2020-02-01
26 citations
Randomized, multicenter, controlled evaluation of S-1 and oxaliplatin (SOX regimen) as neoadjuvant chemotherapy for advanced gastric cancer patients (RESONANCE trial).
Journal of Clinical Oncology
2014-01-20
2 citations